Overview
In this short, educational webinar, Dr. Luis Barreiro, principal investigator of the Barreiro lab at the University of Chicago, will present a summary of the paper, “Genetic ancestry effects on the response to viral infection are pervasive but cell type specific”, published in Science. Dr. Barreiro will discuss how he used a combination of sequencing services provided by BGI to uncover the molecular mechanisms that underpin differences in immune responses.
Dr. Joseph Pickrell, CEO of Gencove, will then drill down into how Gencove and BGI’s combined low-pass whole-genome sequencing (lpWGS) and imputation service, which was used in the study, reduces population biases and enables powerful downstream analysis.
What will you learn in this webinar?
The talks take around 25 minutes followed by a question and answer session.
BGI metagenomic sequencing services are typically executed with our proprietary DNBSEQ™ NGS technology platform, for great sequencing data at the lowest cost in the industry.
DNBSEQ™ is a proprietary sequencing technology, first developed by BGI's Complete Genomics subsidiary in Silicon Valley, and can offer advantages in terms of lower amplification error rates and much lower duplication rates for some sequencing applications. In addition, studies have shown the index hopping rate in DNBSEQ™ platforms can be much lower when compared to that of other platforms.
CopyrightⒸ BGI 2024. All rights reserved. All product names, logos, and brands are property of their respective owners. All company, product and service names used in this email are for identification purposes only. Use of these names, logos, and brands does not imply endorsement. This email contains information on services or products targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information, which may not comply with any legal process, regulation, registration, or usage in the country of your origin. We hereby disclose that this email communication is for commercial purposes. Unless otherwise informed, certain sequencers and sequencing reagents are not available in selected countries or regions. Please get in touch with a representative for regional availability. The company reserves the right of final interpretation.